Caption: Recent interview for Modern Wall Street

Credit: BriaCell Therapeutics

Related Press Releases

FDA Approves the Roll-over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to BriaVax in Patients with Advanced Breast Cancer

Link to this video

Email & IM:

HTML Code:

Video Information

Headline:
Breast Cancer Vaccine Trials: Spotlight on BriaVax

Source:
BriaCell Therapeutics

Release date:
Monday Oct 30, 2017

Release time:
11:51 am